News | Women's Health | October 01, 2019

Volpara Solutions Celebrates 10 Years

Volpara's volumetric breast imaging tools help maintain accuracy and consistency in screening

Volpara's breast density scale

Levels of breast density.

Celebrating its 10th Anniversary in 2019, Volpara Solutions remains committed to helping breast imaging centers achieve improved mammographic sensitivity and detect breast cancers earlier. Since launching Volpara Density  software in 2010, the company has pioneered a robust suite of quantitative breast imaging tools that enable personalized measurements of volumetric density, breast compression, and breast positioning on every mammogram—factors designed to maintain image quality and provide critical insight for breast imaging workflow.

Volpara boasts many accomplishments in its 10-year history. Some of the most notable include the following:

  • Over 100 peer-reviewed papers, making VolparaDensity the most clinically validated automatic, volumetric breast density assessment software in the world
  • Density assessments for more than 20 million women across 37 countries
  • Software installed in more than 300 leading facilities worldwide, including the top two cancer centers in the United States, according to the latest hospital rankings from US News & World Report
  • More than 1 million mammographic and tomosynthesis studies evaluated for positioning and compression stored in the Volpara Enterprise cloud
  • Recurring revenue growth of over 3,000% since listing on the ASX in 2016

"Volpara was founded for very personal reasons, as we each had friends and family members die of breast cancer. However, with more than 500,000 breast cancers deaths worldwide each year, our vision quickly expanded to a focus on helping save all families from breast cancer," said Ralph Highnam, PhD, founder and CEO, Volpara Solutions. "Building on the hugely successful adoption of VolparaDensity over the past 10 years, we have been able to make women and physicians understand the importance of breast density and help shift the conversation to risk and personalized medicine. We are extremely proud of the progress we've made and thank all of our employees, industry partners, researchers, and customers as we look forward to the next 10 years of progress."

According to Highnam, the achievements of the first 10 years may best be summarized by a recent customer comment: "with Volpara, we are making screening more accurate, more comfortable, safer, more cost-effective and making a difference daily."

For more information: 

Related Content

Guerbet presented its Contrast&Care injection management solution at ECR 2018

News | Contrast Media | November 13, 2019
November 13, 2019 – Guerbet, a global specialist in...
Mindray announced its partnership with Cincinnati Children's Hospital Medical Center, one of the top children's hospitals in the United States
News | Ultrasound Imaging | November 13, 2019
November 13, 2019 – Mindray announced its partnership with...
 MaxQ AI
News | Artificial Intelligence | November 13, 2019
November 13, 2019 – MaxQ AI announced a new partnership agreement with...
 Paxera Ultima 360
News | Enterprise Imaging | November 12, 2019
November 12, 2019 — Medical Imaging developer PaxeraHealth will showcase the
 Mammography doctor
News | Breast Imaging | November 12, 2019
November 12, 2019 — Geisinger has partnered with...
 Lunit RSNA
News | Artificial Intelligence | November 12, 2019
November 12, 2019 — Lunit, a leading medical AI software company devoted to provi